Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation
Optimal antithrombotic treatment of older patients is usually impeded by several prevailing misconceptions. The aim of our study was to assess the type, dosage and predictors of antithrombotic therapy in older patients with non-valvular atrial fibrillation (NVAF). PAVE-AF was a prospective, cross-se...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829237/ https://www.ncbi.nlm.nih.gov/pubmed/32519166 http://dx.doi.org/10.1007/s11239-020-02167-8 |